Literature DB >> 8929881

Neuropsychologic development in early treated congenital hypothyroidism: analysis of literature data.

G Derksen-Lubsen1, P H Verkerk.   

Abstract

The aim of this study was to determine the neuropsychologic development in patients with congenital (primary) hypothyroidism (CH) detected by screening and treated from early age. Seven studies were evaluated, including 675 CH patients and 570 controls. Criteria for inclusion of the studies were: 1) age of patients and controls > or = 5 y; 2) control group well defined in the original article. A meta-analysis of the data on the intellectual development was performed. All analyzed studies show a trend toward lower intelligence quotient (IQ) and--as far as investigated--poorer motor skills in CH patients compared with controls. Pooling of data showed a significant deficit of the mean IQ of 6.3 (95% confidence interval: 4.7-7.8). The most important independent risk factor for the eventual outcome appears to be the severity of CH (defined by initial thyroxine at the moment of diagnosis and by skeletal maturation); treatment variables do not seem to have an important effect the cognitive development. We conclude that CH, despite early detection and treatment, results in an IQ deficit; the severity of CH seems to be the most important individual risk factor. Our second conclusion is that, although biomedical risk factors are well investigated, the individual weight of these factors is yet largely unknown. This may be due to the variability of definitions and test tools, especially for the investigation of motor skills, that have been used.

Entities:  

Mesh:

Year:  1996        PMID: 8929881     DOI: 10.1203/00006450-199603000-00028

Source DB:  PubMed          Journal:  Pediatr Res        ISSN: 0031-3998            Impact factor:   3.756


  14 in total

1.  Optimisation of thyroxine dose in congenital hypothyroidism.

Authors:  P C Hindmarsh
Journal:  Arch Dis Child       Date:  2002-02       Impact factor: 3.791

Review 2.  Genetics of congenital hypothyroidism.

Authors:  S M Park; V K K Chatterjee
Journal:  J Med Genet       Date:  2005-05       Impact factor: 6.318

3.  Congenital hypothyroidism: no adverse effects of high dose thyroxine treatment on adult memory, attention, and behaviour.

Authors:  B Oerbeck; K Sundet; B F Kase; S Heyerdahl
Journal:  Arch Dis Child       Date:  2005-02       Impact factor: 3.791

Review 4.  Hormones and cognition: current concepts and issues in neuropsychology.

Authors:  D M Erlanger; K C Kutner; A R Jacobs
Journal:  Neuropsychol Rev       Date:  1999-12       Impact factor: 7.444

Review 5.  The role and potential sites of action of thyroid hormone in timing the onset of puberty in male primates.

Authors:  David R Mann; Tony M Plant
Journal:  Brain Res       Date:  2010-09-29       Impact factor: 3.252

6.  Hypothyroidism in children beyond 5 y of age: delayed diagnosis of congenital hypothyroidism.

Authors:  Anju Seth; Varun Aggarwal; Anu Maheshwari
Journal:  Indian J Pediatr       Date:  2012-01-12       Impact factor: 1.967

7.  Neurocognitive functions in children and adolescents with subclinical hypothyroidism.

Authors:  Ayça Törel Ergür; Yasemen Taner; Evşen Ata; Efnan Melek; Emel Erdoğan Bakar; Tanzer Sancak
Journal:  J Clin Res Pediatr Endocrinol       Date:  2012-03

Review 8.  Congenital hypothyroidism: a review of current diagnostic and treatment practices in relation to neuropsychologic outcome.

Authors:  Joanne Rovet; Denis Daneman
Journal:  Paediatr Drugs       Date:  2003       Impact factor: 3.930

Review 9.  Optimising outcome in congenital hypothyroidism; current opinions on best practice in initial assessment and subsequent management.

Authors:  Malcolm Donaldson; Jeremy Jones
Journal:  J Clin Res Pediatr Endocrinol       Date:  2012-11-15

10.  Health- related quality of life and self-worth in 10-year old children with congenital hypothyroidism diagnosed by neonatal screening.

Authors:  Liesbeth van der Sluijs Veer; Marlies Je Kempers; Heleen Maurice-Stam; Bob F Last; Tom Vulsma; Martha A Grootenhuis
Journal:  Child Adolesc Psychiatry Ment Health       Date:  2012-10-03       Impact factor: 3.033

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.